# Trade Mark Journal No.2026/013 27 March 2026

## UK00004355280 16 March 2026 (42,44)

NEOSELECT

International priority date claimed: 10 October 2025 (United States of America) (99436178)

Class 42
  Medical and scientific research and analysis in the fields of genetics, oncology, immunology and proteomics; Providing medical and scientific research information in the fields of genetics, oncology, immunology and proteomics; Providing online non-downloadable software for use in analyzing human tissues, cells and proteins; Providing online nondownloadable software for use in immunology and the development of therapeutics for treating cancer and infectious diseases; genetic testing for scientific research and analysis purposes in the fields of oncology, immunology, and development of therapeutics for treating cancer and infectious diseases.
Class 44
  Genetic testing for medical purposes; genetic counseling; Medical testing and analysis services for diagnostic and treatment purposes.

Natera, Inc.

Representative: J A Kemp LLP